Two Amino Acid Substitutions within the First External Loop of CCR5 Induce Human Immunodeficiency Virus-Blocking Antibodies in Mice and Chickens

ABSTRACT Antibodies to the first loop (ECL1) of CCR5 have been identified in human immunodeficiency virus (HIV)-exposed uninfected individuals (ESN) and in HIV-positive nonprogressing subjects. Thus, these antibodies may confer resistance against HIV infection. To define which amino acids are involved in antibody binding to CCR5, we performed a peptide-scanning assay and studied the immunogenicity of peptides in animal models. A panel of synthetic peptides spanning the CCR5-ECL1 region and displaying glycine or alanine substitutions was assayed for antibody binding with a pool of natural anti-CCR5 antibodies. We used mice and chickens to study the immunogenicity of mutagenized peptide. Structural characterization by nuclear magnetic resonance (NMR) spectroscopy and molecular dynamics simulations were performed to better understand the structural and conformational features of the mutagenized peptide. Amino acid substitutions in positions Ala95 and Ala96 (A95-A96) increased antibody-peptide binding compared to that of the wild-type peptide (Asp95-Phe96). The Ala95-96 peptide was shown to induce, in mice and chickens, antibodies displaying biological activity at very low concentrations. Strikingly, chicken antibodies to the Ala95-96 peptide specifically recognize human CCR5 molecules, downregulate receptors from lymphocytes, inhibit CCR5-dependent chemotaxis, and prevent infection by several R5 viruses, displaying 50% inhibitory concentrations of less than 3 ng/ml. NMR spectroscopy and molecular dynamics simulations proved the high flexibility of isolated epitopes and suggested that A95-A96 substitutions determine a slightly higher tendency to generate helical conformations combined with a lower steric hindrance of the side chains in the peptides. These findings may be relevant to the induction of strong and efficient HIV-blocking antibodies.

[1]  G. Fields,et al.  Solid phase peptide synthesis utilizing 9-fluorenylmethoxycarbonyl amino acids. , 2009, International journal of peptide and protein research.

[2]  John P. Moore,et al.  Antiretroviral drug-based microbicides to prevent HIV-1 sexual transmission. , 2008, Annual review of medicine.

[3]  R. Stevens,et al.  High-Resolution Crystal Structure of an Engineered Human β2-Adrenergic G Protein–Coupled Receptor , 2007, Science.

[4]  R. Stevens,et al.  GPCR Engineering Yields High-Resolution Structural Insights into β2-Adrenergic Receptor Function , 2007, Science.

[5]  M. Burghammer,et al.  Crystal structure of the human β2 adrenergic G-protein-coupled receptor , 2007, Nature.

[6]  J. Irving,et al.  Peptide mimotopes selected with HIV‐1‐blocking monoclonal antibodies against CCR5 represent motifs specific for HIV‐1 entry , 2007, Immunology and cell biology.

[7]  Peter D. Kwong,et al.  Structures of the CCR5 N Terminus and of a Tyrosine-Sulfated Antibody with HIV-1 gp120 and CD4 , 2007, Science.

[8]  M. Colvin,et al.  The epidemiology of HIV in South African workplaces , 2007, AIDS.

[9]  L. Lopalco,et al.  Natural mucosal antibodies reactive with first extracellular loop of CCR5 inhibit HIV-1 transport across human epithelial cells , 2007, AIDS.

[10]  L. Lopalco,et al.  Long-lasting CCR5 internalization by antibodies in a subset of long-term nonprogressors: a possible protective effect against disease progression. , 2006, Blood.

[11]  Gerrit Groenhof,et al.  GROMACS: Fast, flexible, and free , 2005, J. Comput. Chem..

[12]  Shrikant Deshpande,et al.  Production of human monoclonal antibody in eggs of chimeric chickens , 2005, Nature Biotechnology.

[13]  L. Lopalco,et al.  Induction of Murine Mucosal CCR5-Reactive Antibodies as an Anti-Human Immunodeficiency Virus Strategy , 2005, Journal of Virology.

[14]  L. Lopalco,et al.  Predictive value of anti-cell and anti-human immunodeficiency virus (HIV) humoral responses in HIV-1-exposed seronegative cohorts of European and Asian origin. , 2005, The Journal of general virology.

[15]  Xiaohong Wang,et al.  Selection of active ScFv to G-protein-coupled receptor CCR5 using surface antigen-mimicking peptides. , 2004, Biochemistry.

[16]  L. Lopalco,et al.  CCR5-specific mucosal IgA in saliva and genital fluids of HIV-exposed seronegative subjects. , 2004, Blood.

[17]  L. Lopalco.  Humoral immunity in HIV-1 exposure: cause or effect of HIV resistance? , 2004, Current HIV research.

[18]  Alfonso Valencia,et al.  Identification of amino acid residues crucial for chemokine receptor dimerization , 2004, Nature Immunology.

[19]  J. Binley,et al.  Redox-Triggered Infection by Disulfide-Shackled Human Immunodeficiency Virus Type 1 Pseudovirions , 2003, Journal of Virology.

[20]  M. Paterlini,et al.  Structure modeling of the chemokine receptor CCR5: implications for ligand binding and selectivity. , 2002, Biophysical journal.

[21]  L. Lopalco,et al.  Serum IgA of HIV-exposed uninfected individuals inhibit HIV through recognition of a region within the α-helix of gp41 , 2002, AIDS.

[22]  Q. Sattentau,et al.  Occupancy and mechanism in antibody-mediated neutralization of animal viruses. , 2002, The Journal of general virology.

[23]  M. Alizon,et al.  Determinants of the trans-Dominant Negative Effect of Truncated Forms of the CCR5 Chemokine Receptor* , 2001, The Journal of Biological Chemistry.

[24]  C. Martínez-A,et al.  HIV-1 infection through the CCR5 receptor is blocked by receptor dimerization. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[25]  L. Lopalco,et al.  CCR5-Reactive Antibodies in Seronegative Partners of HIV-Seropositive Individuals Down-Modulate Surface CCR5 In Vivo and Neutralize the Infectivity of R5 Strains of HIV-1 In Vitro1 , 2000, The Journal of Immunology.

[26]  Paola Fusi,et al.  A single-point mutation in the extreme heat- and pressure-resistant sso7d protein from sulfolobus solfataricus leads to a major rearrangement of the hydrophobic core. , 1999, Biochemistry.

[27]  J. Lisziewicz,et al.  Control of HIV despite the discontinuation of antiretroviral therapy. , 1999, The New England journal of medicine.

[28]  X. Daura,et al.  Peptide Folding: When Simulation Meets Experiment , 1999 .

[29]  J. Sodroski,et al.  A Tyrosine-Rich Region in the N Terminus of CCR5 Is Important for Human Immunodeficiency Virus Type 1 Entry and Mediates an Association between gp120 and CCR5 , 1998, Journal of Virology.

[30]  H. Schuitemaker,et al.  Infectious Cellular Load in Human Immunodeficiency Virus Type 1 (HIV-1)-Infected Individuals and Susceptibility of Peripheral Blood Mononuclear Cells from Their Exposed Partners to Non-Syncytium-Inducing HIV-1 as Major Determinants for HIV-1 Transmission in Homosexual Couples , 1998, Journal of Virology.

[31]  William C. Olson,et al.  Amino-Terminal Substitutions in the CCR5 Coreceptor Impair gp120 Binding and Human Immunodeficiency Virus Type 1 Entry , 1998, Journal of Virology.

[32]  Marc Parmentier,et al.  The Second Extracellular Loop of CCR5 Is the Major Determinant of Ligand Specificity* , 1997, The Journal of Biological Chemistry.

[33]  Q. Sattentau,et al.  Relevance of the antibody response against human immunodeficiency virus type 1 envelope to vaccine design. , 1997, Immunology letters.

[34]  J. Moore.  Coreceptors--Implications for HIV Pathogenesis and Therapy , 1997, Science.

[35]  J. Cohen.  Exploiting the HIV-Chemokine Nexus , 1997, Science.

[36]  P. Argos,et al.  Knowledge‐based protein secondary structure assignment , 1995, Proteins.

[37]  R. Connor,et al.  Vpr is required for efficient replication of human immunodeficiency virus type-1 in mononuclear phagocytes. , 1995, Virology.

[38]  G. Wagner,et al.  Recognition of DNA by GAL4 in solution: use of a monomeric protein-DNA complex for study by NMR. , 1994, Biochemistry.

[39]  V. Saudek,et al.  Gradient-tailored excitation for single-quantum NMR spectroscopy of aqueous solutions , 1992, Journal of biomolecular NMR.

[40]  P. Kollman,et al.  Settle: An analytical version of the SHAKE and RATTLE algorithm for rigid water models , 1992 .

[41]  F. Richards,et al.  The chemical shift index: a fast and simple method for the assignment of protein secondary structure through NMR spectroscopy. , 1992, Biochemistry.

[42]  D. King,et al.  A cleavage method which minimizes side reactions following Fmoc solid phase peptide synthesis. , 1990, International journal of peptide and protein research.

[43]  K. Wüthrich.  NMR of proteins and nucleic acids , 1988 .

[44]  T. Straatsma,et al.  THE MISSING TERM IN EFFECTIVE PAIR POTENTIALS , 1987 .

[45]  S W Englander,et al.  Main-chain-directed strategy for the assignment of 1H NMR spectra of proteins. , 1987, Biochemistry.

[46]  H. Berendsen,et al.  Molecular dynamics with coupling to an external bath , 1984 .

[47]  K. Wüthrich,et al.  Application of phase sensitive two-dimensional correlated spectroscopy (COSY) for measurements of 1H-1H spin-spin coupling constants in proteins. , 1983, Biochemical and biophysical research communications.

[48]  W. Delano.  The PyMOL Molecular Graphics System , 2002 .

[49]  C. Martínez-A,et al.  Chemokine signaling and functional responses: the role of receptor dimerization and TK pathway activation. , 2001, Annual review of immunology.

[50]  J. Farber,et al.  Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease. , 1999, Annual review of immunology.

[51]  Alan E. Mark,et al.  The GROMOS96 Manual and User Guide , 1996 .

[52]  J. Sedlák,et al.  Estimation of total, protein-bound, and nonprotein sulfhydryl groups in tissue with Ellman's reagent. , 1968, Analytical biochemistry.